Your browser doesn't support javascript.
loading
Impact of Combined Use of Blood-based Inflammatory Markers on Patients with Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy: Proposal of a Cumulative Marker Score as a Novel Predictive Tool for Prognosis.
Tanaka, Nobuyuki; Kikuchi, Eiji; Kanao, Kent; Matsumoto, Kazuhiro; Shirotake, Suguru; Miyazaki, Yasumasa; Kobayashi, Hiroaki; Kaneko, Gou; Hagiwara, Masayuki; Ide, Hiroki; Obata, Jun; Hoshino, Katsura; Hayakawa, Nozomi; Kosaka, Takeo; Hara, Satoshi; Nakagawa, Ken; Jinzaki, Masahiro; Oya, Mototsugu.
Afiliação
  • Tanaka N; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
  • Kikuchi E; Department of Urology, Keio University School of Medicine, Tokyo, Japan. Electronic address: eiji-k@kb3.so-net.ne.jp.
  • Kanao K; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
  • Matsumoto K; Department of Urology, Keio University School of Medicine, Tokyo, Japan; Department of Urology, Saiseikai Central Hospital, Tokyo, Japan.
  • Shirotake S; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
  • Miyazaki Y; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
  • Kobayashi H; Department of Urology, Keio University School of Medicine, Tokyo, Japan; Department of Urology, Kyosai Tachikawa Hospital, Tokyo, Japan.
  • Kaneko G; Department of Urology, Keio University School of Medicine, Tokyo, Japan; Department of Urology, Kawasaki City Hospital, Tokyo, Japan.
  • Hagiwara M; Department of Urology, Keio University School of Medicine, Tokyo, Japan; Department of Urology, Ichikawa General Hospital, Tokyo Dental College, Ichikawa, Japan.
  • Ide H; Department of Urology, Keio University School of Medicine, Tokyo, Japan; Department of Urology, Inagi City Hospital, Tokyo, Japan.
  • Obata J; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
  • Hoshino K; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
  • Hayakawa N; Department of Urology, Keio University School of Medicine, Tokyo, Japan; Department of Urology, Saiseikai Central Hospital, Tokyo, Japan.
  • Kosaka T; Department of Urology, Keio University School of Medicine, Tokyo, Japan; Department of Urology, Irumagawa Hospital, Saitama, Japan.
  • Hara S; Department of Urology, Kawasaki City Hospital, Tokyo, Japan.
  • Nakagawa K; Department of Urology, Ichikawa General Hospital, Tokyo Dental College, Ichikawa, Japan.
  • Jinzaki M; Department of Diagnostic Radiology, Keio University School of Medicine, Tokyo, Japan.
  • Oya M; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
Eur Urol Focus ; 1(1): 54-63, 2015 Aug.
Article em En | MEDLINE | ID: mdl-28723357
ABSTRACT

BACKGROUND:

Previous studies showed the prognostic impact of preoperative levels of neutrophil-to-lymphocyte ratio (NLR), plasma fibrinogen, and serum C-reactive protein (CRP) in surgically treated upper tract urothelial carcinoma; however, few papers have discussed the proper use of these indices.

OBJECTIVE:

To investigate whether combinations of these three markers, as a cumulative marker score (CMS), improve the accuracy of prognostic models following radical nephroureterectomy (RNU). DESIGN, SETTING, AND

PARTICIPANTS:

A total of 394 patients from multiple institutions were included. Median follow-up was 30 mo. INTERVENTION All patients underwent RNU without neoadjuvant chemotherapy. OUTCOME MEASUREMENTS AND STATISTICAL

ANALYSIS:

Associated outcomes were assessed using multivariate analysis. The CMS was defined as the number of elevated levels of preoperative NLR, plasma fibrinogen, and serum CRP. RESULTS AND

LIMITATIONS:

Multivariate analyses revealed that an increasing CMS was independently associated with high rates of disease recurrence, cancer-specific mortality, and all-cause mortality following RNU. Addition of the CMS to a model that included standard clinicopathologic predictors significantly improved predictive accuracy by 2.7% for disease recurrence, 3.9% for cancer-specific mortality, and 4.0% for all-cause mortality, which were the highest among other prognostic models using each marker alone or combinations of two. The study is limited by its retrospective nature.

CONCLUSIONS:

Although the use of each inflammatory marker alone may be as predictive as clinicopathologic indices for prognosis, combinations like CMS can provide more accurate prognostic models following RNU. PATIENT

SUMMARY:

Elevation of blood-based inflammatory markers may be useful for predicting prognosis because of their low cost and accessibility. Among blood-based indices, we examined the efficacy of preoperative neutrophil-to-lymphocyte ratio, plasma fibrinogen, and serum C-reactive protein levels. Although use of each marker alone provides additional prognostic information, the combination of all three markers would be more predictive than any single marker or combinations of two.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Eur Urol Focus Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Eur Urol Focus Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Japão